RYGNAR
Live / Allowed — Fourth extension granted (statement of use) (as of 22 Oct 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 22 Dec 2023 filing date already counts against anyone who files later.
Record
- Serial number
- 98328532
- Mark type
- Word mark
- Filed
- 22 Dec 2023
- Published for opposition
- 03 Sept 2024
- Attorney of record
- Sarah P. Harrell
Goods and services
- Class 005 — Pharmaceuticals: Vaccines; therapeutic vaccines; therapeutic vaccines for the treatment of Human Papilloma Virus (HPV) and HPV-related disorders and diseases, in particular disorders and diseases caused by one or both of HPV 6 and HPV 11, including Recurrent Respiratory Papillomatosis (RRP); pharmaceutical preparations and substances for the treatment of Human Papilloma Virus (HPV) and HPV-related disorders and diseases, in particular disorders and diseases caused by one or both of HPV 6 and HPV 11, including Recurrent Respiratory Papillomatosis (RRP)
Owner
- Precigen, Inc., Germantown, MD, US
- Precigen, Inc., Germantown, MD, US
Prosecution history
- 22 Oct 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 22 Oct 2026 — SOU EXTENSION 4 GRANTED
- 22 Oct 2026 — SOU EXTENSION 4 FILED
- 22 Oct 2026 — SOU TEAS EXTENSION RECEIVED
- 23 Apr 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Apr 2026 — SOU EXTENSION 3 GRANTED
- 23 Apr 2026 — SOU EXTENSION 3 FILED
- 23 Apr 2026 — SOU TEAS EXTENSION RECEIVED
- 01 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Sept 2025 — SOU EXTENSION 2 GRANTED
- 30 Sept 2025 — SOU EXTENSION 2 FILED
- 30 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 28 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 28 Mar 2025 — SOU EXTENSION 1 GRANTED
- 28 Mar 2025 — SOU EXTENSION 1 FILED